Harvard Bioscience Overview

  • Year Founded
  • 1901

Year Founded

  • Status
  • Public

  • Employees
  • 416


  • Stock Symbol
  • HBIO

Stock Symbol

  • Investments
  • 20

  • Share Price
  • $3.26
  • (As of Friday Closing)

Harvard Bioscience General Information


Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Other Devices and Supplies
Other Industries
Stock Exchange
Corporate Office
  • 84 October Hill Road
  • Suite 10
  • Holliston, MA 01746
  • United States
+1 (508) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Harvard Bioscience Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.26 $3.28 $2.70 - $5.71 $142M 43.4M 150K -$0.20

Harvard Bioscience Financials Summary

In Thousands,
TTM 31-Mar-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 222,503 268,328 167,162 336,219
Revenue 106,787 112,250 113,335 118,904
EBITDA 2,179 8,035 969 9,021
Net Income (8,731) (3,415) (9,516) (288)
Total Assets 133,161 137,366 145,360 162,344
Total Debt 41,364 42,773 54,241 56,960
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Harvard Bioscience Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Harvard Bioscience‘s full profile, request access.

Request a free trial

Harvard Bioscience Comparisons

HQ Location
Total Raised
Post Valuation
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that
Other Devices and Supplies
Holliston, MA
416 As of 2023
000000 - 000 0000

000 00

eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt i
Pleasanton, CA
0000 As of 0000


nim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip e
0000000000 000000000
Kobe, Japan
00000 As of 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Harvard Bioscience Competitors (21)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
10x Genomics Private Equity-Backed Pleasanton, CA 0000 00.000 000000000
Sysmex (Diagnostic Equipment) Corporation Kobe, Japan 00000 00000000
Repligen Corporation Waltham, MA 0000 00000000
Lonza Group Corporation Basel, Switzerland 00000 00000 000000000000 00000
Roche Corporation Basel, Switzerland 000000 00.000 000000000000 00.000
You’re viewing 5 of 21 competitors. Get the full list »

Harvard Bioscience Patents

Harvard Bioscience Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230357695-A1 Systems and methods for holding an instrument in a petri dish Pending 04-May-2022 000000000
DE-202011103215-U1 Bioreactor Inactive 07-Jul-2011 000000000
DE-102011107400-B3 Bioreactor Inactive 07-Jul-2011 0000000000 0
US-20100102008-A1 Backpressure regulator for supercritical fluid chromatography Inactive 27-Oct-2008 000000000 00
US-20090249801-A1 Cold trap to increase gas residence time to increase condensation of vapor molecules Inactive 04-Apr-2008 B01D5/0003 0
To view Harvard Bioscience’s complete patent history, request access »

Harvard Bioscience Executive Team (12)

Name Title Board Seat Contact Info
James Green Chief Executive Officer & Chairman
Jennifer Cote Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
You’re viewing 2 of 12 executive team members. Get the full list »

Harvard Bioscience Board Members (14)

Name Representing Role Since
0000 000000 Self Board Member 000 0000
00000000 000 Self Board Member 000 0000
00000 00000 Harvard Bioscience Chief Executive Officer & Chairman 000 0000
000000000 0000 00 Self Board Member 000 0000
000000 0000000 Self Board Member 000 0000
You’re viewing 5 of 14 board members. Get the full list »

Harvard Bioscience Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Harvard Bioscience Acquisitions (20)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Data Sciences International 31-Jan-2018 0000000000 000.00 Monitoring Equipment 0000000 0
HEKA Elektronik Dr. Schulze 08-Jan-2015 0000000000 00.000 Diagnostic Equipment 0000000 0
Triangle BioSystems International 01-Oct-2014 0000000000 00.00 Monitoring Equipment 0000000 0
AHN Biotechnologie 03-Feb-2012 0000000000 00.000 Other Devices and Supplies
CMA Microdialysis 01-Jul-2011 Merger/Acquisition 00000 Medical Supplies 00000 000
You’re viewing 5 of 20 acquisitions. Get the full list »

Harvard Bioscience Subsidiaries (11)

Company Name Industry Location Founded
KD Scientific Electronic Equipment and Instruments Holliston, MA 2004
Union Biometrica Distributors/Wholesale Holliston, MA 0000
Warner Instruments Other Pharmaceuticals and Biotechnology Holliston, MA 0000
Data Sciences International Monitoring Equipment Saint Paul, MN 0000
BTX Other Devices and Supplies Holliston, MA 0000
You’re viewing 5 of 11 subsidiaries. Get the full list »

Harvard Bioscience ESG

Risk Overview

Risk Rating

Updated March, 01, 2024

22.87 | Med Risk

Risk Scale

A lower score indicates better sustainability












Exposure refers to the extent to which a company is exposed to different material ESG issues



Management is related to actions taken to manage ESG issues


Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.


Covered Companies

00 of 16,216






00 of 921




Laboratory Equipment and Services


00 of 64




To view Harvard Bioscience’s complete esg history, request access »

Harvard Bioscience Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
AHN Biotechnologie 03-Feb-2012 000000000000000000 00.000 Completed
  • 0000000 0000000000
Denville Scientific 02-Sep-2009 Merger/Acquisition 000.00 Completed
To view Harvard Bioscience’s complete exits history, request access »

Harvard Bioscience FAQs

  • When was Harvard Bioscience founded?

    Harvard Bioscience was founded in 1901.

  • Who is the CEO of Harvard Bioscience?

    James Green is the CEO of Harvard Bioscience.

  • Where is Harvard Bioscience headquartered?

    Harvard Bioscience is headquartered in Holliston, MA.

  • What is the size of Harvard Bioscience?

    Harvard Bioscience has 416 total employees.

  • What industry is Harvard Bioscience in?

    Harvard Bioscience’s primary industry is Other Devices and Supplies.

  • Is Harvard Bioscience a private or public company?

    Harvard Bioscience is a Public company.

  • What is Harvard Bioscience’s stock symbol?

    The ticker symbol for Harvard Bioscience is HBIO.

  • What is the current stock price of Harvard Bioscience?

    As of 12-Jul-2024 the stock price of Harvard Bioscience is $3.26.

  • What is the current market cap of Harvard Bioscience?

    The current market capitalization of Harvard Bioscience is $142M.

  • What is Harvard Bioscience’s current revenue?

    The trailing twelve month revenue for Harvard Bioscience is $107M.

  • Who are Harvard Bioscience’s competitors?

    10x Genomics, Sysmex (Diagnostic Equipment), Repligen, Lonza Group, and Roche are some of the 21 competitors of Harvard Bioscience.

  • What is Harvard Bioscience’s annual earnings per share (EPS)?

    Harvard Bioscience’s EPS for 12 months was -$0.20.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »